ablation or tumor News

Consider novel linker strategy techniques to increase efficacy of ADC products

Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

The Precision Converting Services group now offers accurate laser ablation services utilizing digital converting technology to remove conductive coatings and metal foils, eliminating masks and hazardous byproducts associated with chemical etching.

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical – Global Trends & Competitive Analysis

Consider novel linker strategy techniques to increase efficacy of ADC products

Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays

The Precision Converting Services group now offers accurate laser ablation services utilizing digital converting technology to remove conductive coatings and metal foils, eliminating masks and hazardous byproducts associated with chemical etching.

Charity Outing Will Support Foundation’s Leading Edge Brain Cancer Research & Clinical Trials in the Greater New York Metropolitan Area - One Lucky Golfer Who Hits a Hole-in-One Will Win a New Porsche 911 Carrera, Courtesy of Pepe Porsche

Characterisaion of ADC's is a crtitical step for both research and development of efficacious and safe therapeutics

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

The Caring for Carcinoid Foundation (CFCF) is pleased to announce its celebratory programming in honor of Worldwide NET Cancer Awareness Day. CFCF-sponsored events include a Patient Education Seminar and awarding grants to patient support groups.

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

New Medical Devices research report from GlobalData is now available from Fast Market Research

Surgeon to Remove Potentially Deadly Tumor near Brainstem

Many new cancer weapons come as personalized therapies that can target specific changes in an individual’s tumor. Leading the work are Binghamton University researchers who are using a new tool in studying tubulin tyrosine ligase, or TTL enzyme.

Immunolizer® is a natural formula scientifically designed to optimize the immune system's performance. Immunolizer® activates the body's defense mechanisms and helps the Immune System to distinguish adequately between self and non-self.

Recently published research from GlobalData, "Brain Tumor - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

As the Guinness Record holder for operating a 66kg tumor, Dr Makeshwari takes his inspiration from Apple CEO Steve Jobs quote "Innovation distinguishes between a leader and follower."

The study revealed that when the loss of heterozygosity (LOH) was identical (concordant) in the tumors they were metastatic. New multifocal primary cancers had discordant LOH, meaning their LOH was not identical.

Several milestones achieved following its first year treating patients in Suffolk County, New York.

Multiple technologies that produce desired tissue destruction, excision or other tissue effects are competing with each other to drive a high volume of surgical and interventional procedures and markets, according to a new MedMarket Diligence report.

Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence.

“While I was sitting in the 'chemo room' with the transparent fluid dripping into my right arm---I wish I'd had a book like Chemo Club to read” said Louise Moeri, author of Chemo Club, published by Crosspointe Media, Inc. in Modesto, CA.

A brain tumor is an abnormal growth of cells within the brain, which can be cancerous or non-cancerous (benign).

Avastin (bevacizumab; Genentech/Roche/Chugai) is a humanized monoclonal antibody directed towards vascular endothelial growth factor (VEGF). VEGF plays an important role in angiogenesis, a key driver of tumor growth.

Technologies as varied as ultrasound, radiofrequency, hydromechanical and others for the energy-based treatment of tissue are finding an equally broad range of applications in nearly all medical specialties. The result is a $10 billion global market.

Radiotherapy is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

MENA Oncology conference is being organized as a result of the increasing incidences and heightened fear of this disease, will provide information and discuss latest technological developments in the treatment of breast cancer.

Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco.

The new Business Insights report Cancer Market Outlook to 2014: Competitive landscape, market size, pipeline analysis and growth opportunities looks into what the future holds for players in the fastest growing pharmaceutical market.

Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.

Palm Beach Spine & Pain Institute offers Radiofrequency alternatives to Laser Surgery with superior outcomes

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body

Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body.

Venus Day Has Been Recognized for her Volunteer Work by Jeb Bush, the Governor of Florida as a Point of Light Award Recipient

A study to develop a new genetically engineered vaccine opened officially Oct 16. The program has begun screening patients. Initial clinical trial reported rapid shrinkage and/or disappearance of widespread tumors within eight weeks.

Glioblastoma patient using experimental vaccine consisting of his own brain tumor tissue and white blood cells showing results

Bharatbook.com included “Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities” report that provides segmentation of the worldwide ablation market by both ablation technology and region

A new, robotic-assisted minimally invasive thyroid surgery can now offer those with thyroid tumors relief without neck scars. This new procedure is being performed using the daVinci® Surgical System at College Station Medical Center in Texas.

--- NanoTecNexus and NanoTumor Center Education Projects Rank High ---

Korean-FDA approved RNL’s Astrostem based on patient’s own fat derived stem cells to treat spinal cord injury. Phase I human trial will be done by intravenous infusion of stem cells at Sam Hospital in Anyang, South Korea

Dr.. R.K. Mishra, holding Master Degree in Mimimal Access has successfully removed a 20-Kg tumour, known as retroperitoneal tumour from the abdomen of a patient.

The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of divese energy types to tissue.

I.R.I.S Centers announces Dr. Karen A. Starkey M.D., Women’s Care Center in Ahwatukee, Arizona, will now offer Bio-Identical Hormone replacement therapy utilizing hormone pellet insertion.

Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement.

Dr. Karen A. Starkey M.D. has opened a Women’s Care Center in Ahwatukee, Arizona. The practice will also offer the Thermachoice® Ablation and Gynecological Cosmetic Surgery.

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.

Melanoma, a malignant tumor that arises in melanocytes, is the most deadly of all skin cancers.